YOU ARE HERE: LAT HomeCollectionsVaccine


April 29, 1990
On first reading, I thought that "Vaccine to Fight Drug Addiction Is Needed" (March 1) was a Swiftian exercise. But then I realized that satire never appears on the Business pages of The Times. The assumption that desire for euphoria is a disease--that is, an unnatural state--makes for an egregiously false foundation on which to build an argument. For the overwhelming evidence that such a desire (yea, need) is innate rather than abnormal in higher animals, you should read "Intoxication: Life in Pursuit of Artificial Paradise," by Ronald K. Siegel, a Ph.D.
June 28, 2013 | By Brad Balukjian
A "reverse vaccine" that allows people with Type 1 diabetes to produce their own insulin has passed its first test with human subjects, according to a new study. The success points to a potential new strategy for treating those in the early stages of the disease, experts said. The therapy is designed to protect cells in the pancreas that make insulin, a hormone the body needs to convert sugars and starches into energy. In people with Type 1 diabetes, the immune system goes haywire and attacks those crucial insulin-producing cells for reasons that medical researchers don't understand.
July 25, 2009 | Thomas H. Maugh II
Hundreds of thousands of Americans could die over the next two years if the vaccine and other control measures for the new H1N1 influenza are not effective, and, at the pandemic's peak, as much as 40% of the workforce could be affected, according to new estimates from the Centers for Disease Control and Prevention. That is admittedly a worst-case scenario that the federal agency says it doesn't expect to occur.
July 23, 2009 | Times Wire Reports
The federal government and vaccine makers are seeking thousands of volunteers, from babies to the elderly, to test whether a new swine flu vaccine works. The National Institutes of Health tapped a network of medical centers around the country to begin a series of studies on a vaccine for the H1N1 flu pandemic. The first shots will go into the arms of healthy adults, of any age, in early August. If there are no immediate safety concerns, such as allergic reactions, testing would begin in children as young as 6 months.
July 24, 1986 | MARLENE CIMONS, Times Staff Writer
The Food and Drug Administration on Wednesday announced its approval of the first human vaccine produced by genetic engineering, which will be used to protect against Hepatitis B. "This vaccine opens up a whole new era of vaccine production," FDA Commissioner Frank E. Young said at a press conference. "These techniques should be able to be extended to any virus or parasite to produce other vaccines that normally cannot be propagated in the laboratory."
August 16, 1985 | Associated Press
The virus suspected of causing AIDS has so many variations in its genetic structure that developing a vaccine against the disease may be difficult, if it can be done at all, researchers said Thursday. Scientists at the National Cancer Institute said that they looked at samples of the suspect virus found in 18 patients with AIDS or at high risk of getting the disease, and each isolated virus showed a different variation in its genetic structure.
February 3, 2011 | By Shari Roan, Los Angeles Times
Shingles is typically thought of as a once-in-a-lifetime (miserable) experience. But wait! Shingles can recur, even among healthy adults. The illness is caused by the herpes zoster virus. While researchers have known that people with weak immune systems due to other illnesses can develop shingles a second time, healthy people were thought to be one-time-only victims. The illness causes a burning or tingling sensation in the skin in one area of the body followed by blisters that last a few weeks.
June 19, 1989 | WILLIAM R. LONG, Times Staff Writer
There has never been an effective vaccine for malaria, scourge of the tropics and killer of millions. Now, many experts--although cautious--agree that rapidly advancing knowledge about immunology and malaria has reached the threshold of producing a vaccine that can prevent one of the most widespread and troublesome diseases ever known. And in the race to discover a preventive agent, one researcher, Dr. Manuel E. Patarroyo, is claiming victory. Patarroyo has tested his vaccine on hundreds of soldiers stationed in Colombia's Amazon lowlands, where malaria is endemic.
October 11, 2009 | Times Staff and Wire Reports
Several large health maintenance organizations and insurers in California have agreed to refrain from charging co-payments or deductibles for vaccinating patients against the H1N1 flu. State regulators said they obtained agreements from the companies to waive all charges for administering the vaccine, which is provided free by the federal government. "The likelihood that some health insurers would charge some administrative fee for the vaccine was very, very high," state Insurance Commissioner Steve Poizner said in a conference call.
October 23, 1995 | From Times staff and wire reports
A new vaccine to prevent the potentially deadly whooping cough is effective in 71% of cases and produced no side effects, according to a study of 3,450 Swedish children. published in the New England Journal of Medicine. Whooping cough, also known as pertussis, causes a severe cough that lasts for about six weeks and can result in vomiting, choking, an inability to breathe and injury to the brain due to lack of oxygen. The vaccine used in the Swedish study is awaiting approval for use by the Food and Drug Administration.
Los Angeles Times Articles